Ipratropium bromide, a short-acting anticholinergic, treats bronchospasm conditions like a chronic obstructive pulmonary disease, thereby preventing or reducing symptoms like shortness of breath, wheezing, tightness of chest, and cough. Its effects last to a maximum of 6 hours. It inhibits the parasympathetic activity of the airway and results in reduced bronchial secretions and bronchodilation. They come in canisters and as liquids. Dry mouth is a common side effect.
Ipratropium Bromide in Chronic Obstructive Pulmonary Disease: A Comprehensive Review
Ipratropium bromide, a bronchodilator, alleviates airflow limitation in chronic obstructive pulmonary disease by blocking muscarinic receptors.